Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
On February 24, 1868, something extraordinary happened in the U.S. Congress. For the first time in history, the United States House of Representatives impeached a sitting president, Democrat Andrew ...